Pluri (PLUR) Other Operating Expenses (2012 - 2025)
Pluri (PLUR) posted quarterly Other Operating Expenses of -$143000.0 for Q4 2025, down 106.95% year-over-year from $2.1 million in Q4 2024, and down 132.57% quarter-over-quarter from $439000.0 in Q3 2025.
Pluri (PLUR) Other Operating Expenses (2012 - 2025) Analysis & Trends
Pluri (PLUR) has reported Other Operating Expenses for 5 consecutive years, with -$143000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Other Operating Expenses fell 106.95% year-over-year to -$143000.0; the TTM figure through Dec 2025 stood at -$427000.0 (down 119.51% YoY), while the FY2025 annual figure was -$13.0 million, down 875.54% from the prior year.
- Other Operating Expenses slipped to -$143000.0 in Q4 2025 per PLUR's latest filing, from $439000.0 in the prior quarter.
- Across five years, Other Operating Expenses topped out at $2.1 million in Q4 2024 and bottomed at -$1.4 million in Q4 2022.
- Historically, Other Operating Expenses has averaged $87000.0 across 4 years, with a median of $260000.0 in 2023.
- Annual changes were most pronounced in 2024 — Other Operating Expenses jumped 373.1% — and 2025, when it slumped 299.72%.
- Pluri's Other Operating Expenses stood at -$1.4 million in 2022, then jumped by 131.91% to $435000.0 in 2023, then surged by 373.1% to $2.1 million in 2024, then tumbled by 106.95% to -$143000.0 in 2025.
- Business Quant data shows PLUR's Other Operating Expenses at -$143000.0 in Q4 2025, $439000.0 in Q3 2025, and -$723000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Pluri | 16.21 Mn | 3.72 Mn | 86,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -143,000.00 |
| Sep 30, 2025 | 439,000.00 |
| Mar 31, 2025 | -723,000.00 |
| Dec 31, 2024 | 2.06 Mn |
| Sep 30, 2024 | -621,000.00 |
| Jun 30, 2024 | 390,000.00 |
| Mar 31, 2024 | 362,000.00 |
| Dec 31, 2023 | 435,000.00 |
| Sep 30, 2023 | 493,000.00 |
| Jun 30, 2023 | 158,000.00 |
| Mar 31, 2023 | -441,000.00 |
| Dec 31, 2022 | -1.36 Mn |
| Sep 30, 2012 | -1.05 Mn |